Calluna Vulgaris for Urinary Tract Infection Treatment
Summary
USPTO published patent application US20260108573A1 by inventor Heather Florio on April 23, 2026, covering methods and compositions of Calluna vulgaris for the prevention and treatment of urinary tract infections. The application (No. 19322118) was filed on September 8, 2025 and classifies under CPC codes A61K 36/45, A61K 9/14, and A61P 13/02.
“Provided herein are methods and compositions of Calluna vulgaris for the prevention and treatment of Urinary Tract Infections.”
About this source
USPTO classification A61K covers pharmaceutical preparations: formulations, dosage forms, combination therapies, delivery systems, and the vehicles that carry active ingredients. Every newly published application in A61K lands in this feed, around 245 a month. Applications publish 18 months after filing, so this feed reveals what pharma formulators at major sponsors and generics were working on in the prior year and a half. Watch this if you compete in drug formulation, file freedom-to-operate analyses, scout competitive drug products before clinical readouts, or follow novel delivery platforms like nanoparticles, lipid carriers, and long-acting injectables.
What changed
USPTO published patent application US20260108573A1 for Calluna vulgaris extracts and compositions for use in preventing and treating urinary tract infections. The application claims methods of treatment and pharmaceutical compositions containing the plant extract. CPC classifications A61K 36/45 (Capsulothecium), A61K 9/14 (solid pharmaceuticals), and A61P 13/02 (urogenital system treatments) indicate the claimed subject matter covers botanical pharmaceutical formulations and their therapeutic applications.
Patent applicants and pharmaceutical developers researching botanical-based urinary tract infection treatments should review this application to assess prior art implications for their own IP portfolios. While this represents an early-stage patent publication rather than an issued grant, it establishes a public record of the inventors' claimed scope that may affect freedom-to-operate analyses for competing therapies.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
CALLUNA VULGARIS FOR TREATING AND PREVENTING URINARY TRACT INFECTIONS
Application US20260108573A1 Kind: A1 Apr 23, 2026
Inventors
Heather Florio
Abstract
Provided herein are methods and compositions of Calluna vulgaris for the prevention and treatment of Urinary Tract Infections.
CPC Classifications
A61K 36/45 A61K 9/14 A61P 13/02
Filing Date
2025-09-08
Application No.
19322118
Mentioned entities
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.